GlassScriptPhysician profile
Taylor W Covington
NPI 1649552563
$1,494.46
in general payments reported to CMS, 2019-2025
27 companies · $552 in 2025
The $552 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $151 · 2022: $619 · 2023: $16.92 · 2024: $155 · 2025: $552.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $724.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $724.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $286.67 | 2021-2025 | Xtandi |
| Bayer Healthcare Pharmaceuticals INC. | $209.67 | 2021-2025 | |
| Janssen Biotech, INC. | $169.71 | 2024-2025 | Erleada, Akeega |
| Sumitomo Pharma America, INC. | $160.67 | 2024-2025 | Orgovyx, Gemtesa |
| Urogen Pharma, INC. | $78.16 | 2025 | |
| Urovant Sciences INC | $75.41 | 2022 | |
| Abbvie INC. | $48.42 | 2022 | |
| Endo USA, INC. | $47.10 | 2024-2025 | Xiaflex, Aveed |
| Pfizer INC. | $44.44 | 2021-2022 | |
| Teleflex LLC | $43.15 | 2025 | Barrigel |
| Procept Biorobotics Corporation | $35.96 | 2022 | |
| Hollister Incorporated | $33.22 | 2022-2023 | Infyna Chic |
| Amgen INC. | $31.04 | 2022 | |
| Progenics Pharmaceuticals, INC. | $25.67 | 2022 | |
| Myovant Sciences INC. | $21.74 | 2022 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $20.00 | 2022 | |
| Tolmar, INC. | $18.03 | 2025 | Eligard, Jatenzo |
| Galderma Laboratories, L.P. | $17.78 | 2025 | Dysport |
| Telix Pharmaceuticals | $17.02 | 2025 | Illuccix |
| Revance Therapeutics, INC. | $16.22 | 2024 | Daxxify |
| Azurity Pharmaceuticals, INC. | $15.81 | 2025 | Azmiro |
| Myriad Genetic Laboratories, INC. | $15.28 | 2022 | |
| Profound Medical Corp. | $13.21 | 2022 | |
| Abc Home Medical Supply, INC. | $13.07 | 2022 | |
| Coloplast Corp | $12.80 | 2021 | |
| Acerus Pharmaceuticals Corporation | $12.54 | 2022 | |
| Allergan, INC. | $11.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Covington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.